Eli Lilly and Novo Nordisk have announced they are working on new oral drugs that can be used for type-2 diabetes and weight ...
Companies such as Novo Nordisk and Eli Lilly have plans to launch once-daily weight-loss pills in 2026, pending FDA approval, ...